InMed Pharmaceuticals Inc Stock Canadian Securities Exchange
Equities
IN
CA4576371062
Biotechnology & Medical Research
Sales 2024 * | 7.3M 5.34M | Sales 2025 * | 9.12M 6.68M | Capitalization | 2.09M 1.53M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 0.29 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.23 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.64% |
Latest transcript on InMed Pharmaceuticals Inc
Managers | Title | Age | Since |
---|---|---|---|
Eric Adams
CEO | Chief Executive Officer | 61 | 16-06-15 |
Chief Operating Officer | - | 18-11-04 | |
Colin Clancy
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Janet Grove
BRD | Director/Board Member | 57 | 22-02-10 |
Eric Adams
CEO | Chief Executive Officer | 61 | 16-06-15 |
Andrew Hull
CHM | Chairman | 61 | 16-09-11 |
1st Jan change | Capi. | |
---|---|---|
-2.26% | 104B | |
+1.41% | 97.42B | |
+0.79% | 22.2B | |
-17.84% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-17.63% | 15.06B | |
+4.55% | 13.98B | |
+32.11% | 11.66B |